These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9454883)

  • 1. The Knights of the Round Table hypothesis of tumour suppressor gene function--noble sacrifice or sexual dalliance: genes, including p53, BRCA1/2 and RB have evolved by horizontal and vertical transmission of mating factor genes and are involved in gametogenesis, implantation, development and tumourigenesis.
    Gosden CM; Liloglou T; Nunn J; Gardener D; Nickson P; Crampton JM; Field JK
    Int J Oncol; 1998 Jan; 12(1):5-35. PubMed ID: 9454883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 inactivation is a rare event in familial breast tumors negative for BRCA1 and BRCA2 mutations.
    Sensi E; Tancredi M; Aretini P; Cipollini G; Naccarato AG; Viacava P; Bevilacqua G; Caligo MA
    Breast Cancer Res Treat; 2003 Nov; 82(1):1-9. PubMed ID: 14672397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression.
    Nozaki M; Tada M; Kobayashi H; Zhang CL; Sawamura Y; Abe H; Ishii N; Van Meir EG
    Neuro Oncol; 1999 Apr; 1(2):124-37. PubMed ID: 11550308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
    Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
    Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism of tumorigenesis caused by tumor suppressor gene].
    Hayashi Y
    Nihon Rinsho; 2000 Jun; 58(6):1231-6. PubMed ID: 10879046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor surveillance via the ARF-p53 pathway.
    Sherr CJ
    Genes Dev; 1998 Oct; 12(19):2984-91. PubMed ID: 9765200
    [No Abstract]   [Full Text] [Related]  

  • 7. New roles for the RB tumor suppressor protein.
    Liu H; Dibling B; Spike B; Dirlam A; Macleod K
    Curr Opin Genet Dev; 2004 Feb; 14(1):55-64. PubMed ID: 15108806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation.
    Leung SY; Yuen ST; Chan TL; Chan AS; Ho JW; Kwan K; Fan YW; Hung KN; Chung LP; Wyllie AH
    Oncogene; 2000 Aug; 19(35):4079-83. PubMed ID: 10962567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tumor suppressor genes].
    Kuchino Y
    Nihon Rinsho; 1994 Dec; 52(12):3319-29. PubMed ID: 7853729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low expression of bcl-2 in Brca1-associated breast cancers.
    Freneaux P; Stoppa-Lyonnet D; Mouret E; Kambouchner M; Nicolas A; Zafrani B; Vincent-Salomon A; Fourquet A; Magdelenat H; Sastre-Garau X
    Br J Cancer; 2000 Nov; 83(10):1318-22. PubMed ID: 11044356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cell cycle regulation by anti-oncogene].
    Akiyama T
    Tanpakushitsu Kakusan Koso; 1994 Sep; 39(12):2158-62. PubMed ID: 7938611
    [No Abstract]   [Full Text] [Related]  

  • 12. Gain of function mutant p53 proteins cooperate with E2F4 to transcriptionally downregulate RAD17 and BRCA1 gene expression.
    Valenti F; Ganci F; Fontemaggi G; Sacconi A; Strano S; Blandino G; Di Agostino S
    Oncotarget; 2015 Mar; 6(8):5547-66. PubMed ID: 25650659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations.
    Zweemer RP; Shaw PA; Verheijen RM; Ryan A; Berchuck A; Ponder BA; Risch H; McLaughlin JR; Narod SA; Menko FH; Kenemans P; Jacobs IJ
    J Clin Pathol; 1999 May; 52(5):372-5. PubMed ID: 10560359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens.
    Morgenbesser SD; Williams BO; Jacks T; DePinho RA
    Nature; 1994 Sep; 371(6492):72-4. PubMed ID: 8072529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tumor suppressor genes and their role in abnormal production of leukocytes (leukemogenesis)].
    Furukawa Y
    Rinsho Ketsueki; 1993 May; 34(5):572-7. PubMed ID: 8315827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.
    Mote PA; Leary JA; Avery KA; Sandelin K; Chenevix-Trench G; Kirk JA; Clarke CL;
    Genes Chromosomes Cancer; 2004 Mar; 39(3):236-48. PubMed ID: 14732925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53.
    Werness BA; Parvatiyar P; Ramus SJ; Whittemore AS; Garlinghouse-Jones K; Oakley-Girvan I; DiCioccio RA; Wiest J; Tsukada Y; Ponder BA; Piver MS
    J Natl Cancer Inst; 2000 Jul; 92(13):1088-91. PubMed ID: 10880552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation.
    Raveh T; Droguett G; Horwitz MS; DePinho RA; Kimchi A
    Nat Cell Biol; 2001 Jan; 3(1):1-7. PubMed ID: 11146619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter hypermethylation patterns in fallopian tube epithelium of BRCA1 and BRCA2 germ line mutation carriers.
    Bijron JG; van der Groep P; van Dorst EB; Seeber LM; Sie-Go DM; Verheijen RH; van Diest PJ
    Endocr Relat Cancer; 2012 Feb; 19(1):69-81. PubMed ID: 22143498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infrequent loss of heterozygosity of the major tumour suppressor genes in Indian oral cancers.
    Kannan S; Yokozaki H; Jayasree K; Sebastian P; Mathews A; Abraham EK; Nair MK; Tahara E
    Int J Oral Maxillofac Surg; 2002 Aug; 31(4):414-8. PubMed ID: 12361076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.